» Articles » PMID: 33677940

Overweight and Obesity Are Risk Factors for Coronavirus Disease 2019: A Propensity Score-Matched Case-Control Study

Overview
Specialty Endocrinology
Date 2021 Mar 8
PMID 33677940
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Although obesity is a risk factor for infection, whether it has the same effect on coronavirus disease 2019 (COVID-19) need confirming. We conducted a retrospective propensity score matched case-control study to examine the association between obesity and COVID-19. This study included data from the Nationwide COVID-19 Registry and the Biennial Health Checkup database, until May 30, 2020. We identified 2,231 patients with confirmed COVID-19 and 10-fold-matched negative test controls. Overweight (body mass index [BMI] 23 to 24.9 kg/m2; adjusted odds ratio [aOR], 1.16; 95% confidence interval [CI], 1.1.03 to 1.30) and class 1 obesity (BMI 25 to 29.9 kg/m2; aOR, 1.27; 95% CI, 1.14 to 1.42) had significantly increased COVID-19 risk, while classes 2 and 3 obesity (BMI ≥30 kg/m2) showed similar but non-significant trend. Females and those <50 years had more robust association pattern. Overweight and obesity are possible risk factors of COVID-19.

Citing Articles

Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study.

Choi J, Kim K, Song K, Seo G Endocrinol Metab (Seoul). 2023; 38(2):245-252.

PMID: 37016490 PMC: 10164491. DOI: 10.3803/EnM.2023.1662.


Obesity and Coronavirus Disease 2019.

Kim M, Jeon J J Metab Bariatr Surg. 2023; 10(1):1-8.

PMID: 36687755 PMC: 9847647. DOI: 10.17476/jmbs.2021.10.1.1.


Trends of overweight and obesity prevalence in school-aged children among Henan Province from 2000 to 2019.

Zhang Y, Lou H, Huang Y, Wang R, Wen X, Wu C Front Public Health. 2022; 10:1046026.

PMID: 36544796 PMC: 9760942. DOI: 10.3389/fpubh.2022.1046026.


The effects of 105 biological, socioeconomic, behavioral, and environmental factors on the risk of SARS-CoV-2 infection and a severe course of COVID-19: a prospective, explorative cohort study.

Flegr J, Flegr P, Priplatova L Biol Methods Protoc. 2022; 7(1):bpac030.

PMID: 36530561 PMC: 9750789. DOI: 10.1093/biomethods/bpac030.


Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study.

Lopez-Gonzalez A, Jane B, Masmiquel Comas L, Arroyo Bote S, Gonzalez San Miguel H, Ramirez Manent J Nutrients. 2022; 14(14).

PMID: 35889752 PMC: 9319232. DOI: 10.3390/nu14142795.


References
1.
Sanchis-Gomar F, Lavie C, Mehra M, Henry B, Lippi G . Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide. Mayo Clin Proc. 2020; 95(7):1445-1453. PMC: 7236707. DOI: 10.1016/j.mayocp.2020.05.006. View

2.
Seo M, Lee W, Kim S, Kang J, Kang J, Kim K . 2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea. J Obes Metab Syndr. 2019; 28(1):40-45. PMC: 6484940. DOI: 10.7570/jomes.2019.28.1.40. View

3.
Dobner J, Kaser S . Body mass index and the risk of infection - from underweight to obesity. Clin Microbiol Infect. 2017; 24(1):24-28. DOI: 10.1016/j.cmi.2017.02.013. View

4.
Lubrano C, Masi D, Risi R, Balena A, Watanabe M, Mariani S . Is Growth Hormone Insufficiency the Missing Link Between Obesity, Male Gender, Age, and COVID-19 Severity?. Obesity (Silver Spring). 2020; 28(11):2038-2039. PMC: 7461181. DOI: 10.1002/oby.23000. View

5.
Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View